SNAP-8
SNAP-8, also called acetyl octapeptide-3, is a lab-made chain of eight amino acids used as a topical skin-care ingredient. It is studied in skin research for possible effects on the chemical signals that make facial muscles contract.
At a glance
- Peptide
- Not yet audited here; the reference library calls it emerging
- Sources differ. See the source
How much to draw
Full calculator →The reference does not report a single injectable amount for SNAP-8, so the amount is yours to enter. The arithmetic is the same for any vial. How to reconstitute a vial.
What sources report
These are figures published elsewhere, reproduced with their source. Peppersite does not recommend an amount for SNAP-8 or for anything else, and nothing below has been checked against the study it came from.
| Amount | Frequency | Route | Reported by |
|---|---|---|---|
| 3-10% concentration in formulation (solution, not pure peptide) | Twice daily (morning and evening)Continuous use; minimum 28 days for measurable results | topical | Peptide Protocol Wiki |
- Twice daily (morning and evening)Continuous use; minimum 28 days for measurable results
- topical
- Peptide Protocol Wiki
We have not published an audit on SNAP-8. Everything below is reference material, not our own reading of the literature, treat it as a starting point for questions, not as a grade.
How it is thought to work
SNAP-8 is thought to interfere with the machinery that releases the chemical signals telling facial muscles to contract, which could soften the look of expression lines such as forehead lines and crow's feet. Researchers link this to the SNARE complex and SNAP-25, a protein involved in releasing neurotransmitters from nerve endings, the same broad system botulinum toxin acts on, though through a very different and highly specific route. This is a hypothesis drawn largely from work on the related peptide Argireline rather than proof for SNAP-8 itself, and results from a topical product also depend on how well it penetrates skin, its stability, the base it is in, its concentration and how long it is used.
Reported side effects
Reported by users: possible skin reactions to topical products include irritation, redness, burning, stinging, rash or an allergic reaction.
Not ruled out: products contain many ingredients, so a reaction may come from preservatives, fragrance, acids, solvents, penetration enhancers or other actives rather than SNAP-8, which makes it hard to pin a reaction on SNAP-8 alone. Topical peptides are often described as well tolerated in cosmetic literature, but the absence of widespread reports does not prove absence of risk. The FDA advises stopping a cosmetic and seeking medical help for serious reactions, and lists rash, redness, swelling and itching as reasons to stop, with severe swelling, breathing symptoms, widespread rash or eye involvement treated as urgent.
Who should avoid it
People with sensitive skin: a higher chance of irritation from active skincare products.
People with a history of contact dermatitis or allergy: increased risk of irritation or allergic contact dermatitis.
People with eczema or rosacea: listed as a reason to discuss topical actives with a clinician first.
People who have recently had a cosmetic procedure: listed as a reason to discuss topical actives with a clinician first.
People with active dermatitis: listed as a reason to discuss topical actives with a clinician first.
Sources
The reference sections on this page come from a compound library we import, not from our own review of the studies. Our own evidence grade appears only where an audit is linked. Research use only; nothing here is medical advice or a protocol.
5-Amino-1MQ (5-amino-1-methylquinolinium) is a small lab-made molecule, not a true peptide, though it is often sold alongside research peptides. It is studied for shrinking fat cells and raising NAD+ levels, and all evidence so far comes from cell and rodent studies, with no published human trial.
BPC-157 (Body Protection Compound 157) is a lab-made chain of 15 amino acids based on a sequence first found in human gastric juice. It is mostly studied in animal models of tendon, ligament, gut and blood-vessel injury, and human evidence is limited to three small pilots.
Cerluten is an oral peptide bioregulator referenced for nervous system support. Its proposed action, tissue-specific peptide bioregulation, is described as theoretical.
CJC-1295 with DAC is a lab-made 30-amino-acid copy of growth hormone-releasing hormone, altered so it attaches to albumin, a protein in the blood. It was studied in early human trials for its effect on growth hormone and IGF-1 levels.
This is a combination research blend sold as one vial: CJC-1295 without DAC, a copy of growth hormone-releasing hormone, plus Ipamorelin, a short peptide that acts on the ghrelin receptor. It is studied as a GHRH and GHRP pairing in growth-hormone research.
Endoluten is a peptide bioregulator taken by mouth, listed in the reference library as pineal support. Its proposed action, tissue-specific peptide bioregulation, is described as theoretical.